Stay updated with breaking news from 37555810. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Brandywine Global Investment Management LLC boosted its holdings in shares of Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 33.9% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 1,535,016 shares of the biopharmaceutical company’s stock after buying an additional […]
Pearl River Capital LLC acquired a new position in Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 74,778 shares of the biopharmaceutical company’s stock, valued at approximately $5,604,000. Gilead Sciences makes up […]
Nordea Investment Management AB lessened its position in shares of Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 1.7% in the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 738,110 shares of the biopharmaceutical company’s stock after selling 13,003 shares during the period. Nordea Investment Management […]
Nordea Investment Management AB trimmed its position in Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 1.7% during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 738,110 shares of the biopharmaceutical company’s stock after selling 13,003 shares during the quarter. […]
Gilead Sciences (NASDAQ:GILD – Free Report) had its target price trimmed by Royal Bank of Canada from $76.00 to $75.00 in a research note published on Wednesday morning, Benzinga reports. The firm currently has a sector perform rating on the biopharmaceutical company’s stock. Other analysts also recently issued reports about the stock. Deutsche Bank Aktiengesellschaft […]